Mart Saarma

Person

Affiliation Expiration31/12/2009

Curriculum Vitae

Latest publications

  1. Levels of glial cell line-derived neurotrophic factor are decreased, but fibroblast growth factor 2 and cerebral dopamine neurotrophic factor are increased in the hippocampus in parkinson's disease

    Virachit, S., Mathews, K. J., Cottam, V., Werry, E., Galli, E., Rappou, E., Lindholm, P., Saarma, M., Halliday, G. M., Shannon Weickert, C. & Double, K. L., 29 Apr 2019, In : Brain Pathology.

    Research output: Contribution to journalArticleScientificpeer-review

  2. CDNF Protein Therapy in Parkinson’s Disease

    Huttunen, H. J. & Saarma, M., 4 Apr 2019, In : Cell Transplantation.

    Research output: Contribution to journalArticleScientificpeer-review

  3. Characterization of CDNF-Secreting ARPE-19 Cell Clones for Encapsulated Cell Therapy

    Galli, E., Lindholm, P., Kontturi, L-S., Saarma, M., Urtti, A. & Yliperttula, M., 6 Mar 2019, In : Cell Transplantation.

    Research output: Contribution to journalArticleScientificpeer-review

View all (187) »

Latest activities

  1. ERC Scientific Council (External organisation)

    Mart Saarma (Chair)
    20152016

    Activity: Membership typesMembership or other role in national/international committee, council, board

  2. PhD thesis supervision

    Mart Saarma (Supervisor)
    2015

    Activity: Examination typesSupervisor or co-supervisor of doctoral thesis

  3. PhD thesis supervision

    Mart Saarma (Supervisor)
    2015

    Activity: Examination typesSupervisor or co-supervisor of doctoral thesis

View all (75) »

Latest prizes

  1. The Lundbeck Foundation Nordic Research Prize

    Mart Saarma (Recipient), 2009

    Prize: Prizes and awards

  2. EMBO member

    Mart Saarma (Recipient), 2005

    Prize: Prizes and awards

View all (4) »

ID: 16176